Psychological Well-Being: Clinical Trials

41 trials for Psychological Well-Being, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

26 completed, 6 recruiting, 3 unknown, 2 active not recruiting. 41 Phase 2, 6 Phase 1, 2 Phase 3.

By phase and status

PhaseTrialsStatus
Phase 241Completed 26, Recruiting 6, Unknown 3, Active not recruiting 2, Not yet recruiting 2, Enrolling by invitation 1, Withdrawn 1
Phase 16Completed 4, Unknown 1, Withdrawn 1
Phase 32Completed 2

Follow Psychological Well-Being: new trials by email Literature Review of Psychological Well-Being trials Research Report on Psychological Well-Being

Trials (filtered) newest first · largest first

All 41 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Psilocybin for Depression in Veterans
Psilocybin, modafinil, zolpidem - Major Depression
Phase 2Not yet recruitingVA Office of Research and Development1502027-01-012026-10-26
Remote Exercise iNtErvention for Wellbeing (RENEW) Trial
Qualified exercise professional support, Exercise apps - Exercise Adherence (Primary), Depressive Symptoms (Secondary)
Phase 2Not yet recruitingUniversity of British Columbia6642026-11-102026-11-17
Long-Term Outcomes Following HBOT
Hyperbaric Oxygen Therapy (HBOT) - Traumatic Brain Injury, Post-Concussive Symptoms
Phase 2RecruitingSummit Hyperbarics and Wellness352026-06-182026-07-28
Impact of Smell Testing on Health Outcomes
Patient-centered information and education - Olfactory Dysfunction, Wellbeing
Phase 2RecruitingMonell Chemical Senses Center10002026-05-292026-10-06
Evaluating the Effectiveness of the Common Elements Treatment Approach (CETA) in Peru: Mechanisms of Individual and Intergenerational Change
Common Elements Treatment Approach, Enhanced Case Managment - Violence, Parenting
Phase 2RecruitingUniversity of Notre Dame6002026-05-182026-06-25
Sleep Health in U.S. Marines
Sleep Leadership, Circadian, Light, and Sleep Skills in Shipboard Military (CLASS-MC) Personnel Program, Insomnia Coach - Depression, Suicidality
Phase 2RecruitingSan Diego State University8602026-03-312026-04-16
Mindfulness-Assisted Psychedelic Therapy
Psilocybin plus mindfulness training, Psilocybin - Mental Health
Phase 2RecruitingUniversity of Southern California402025-07-302026-08-06
Impact of a Medical-Financial Partnership Intervention on Parent Mental Health, Perinatal Outcomes, and Child Developmental Risk
Medical-Financial Partnership Support - Child Development, Mental Health
Phase 2Enrolling by invitationUniversity of California, Los Angeles12002025-07-072026-07-22
Novel and Conventional Interventions for Cognitive and Emotional Flexibility in Patient Trauma
D-Cycloserine (DCS), Transcranial Magnetic Stimulation, Unified Protocol - Depression, Anxiety
Phase 2Active not recruitingMclean Hospital752025-06-012026-10-09
Promoting Active Therapy: Path to Wellness
Walk-and-talk therapy - Depression, Anxiety, Physical Activity
Phase 2RecruitingKansas State University602025-02-282025-03-05
A Clinical Trial to Assess the Efficacy, Safety, and Tolerability of a Repeat Dose of Fasedienol Nasal Spray for the Acute Treatment of Anxiety in Adults With Social Anxiety Disorder
Fasedienol Nasal Spray - Placebo Nasal Spray, Fasedienol Nasal Spray - Fasedienol Nasal Spray, Placebo Nasal Spray - Placebo Nasal Spray - Social Anxiety Disorder
Phase 2CompletedVistaGen Therapeutics, Inc.612025-01-092026-11-04
Pharmacist-led Intervention for Injectable HIV Treatment for Women With Health-related Social Needs
Collaborative drug therapy management model, Cabotegravir/Rilpivirine - Hiv
Phase 2Active not recruitingYale University502024-08-012026-10-13
Self-Management Program for AIS D SCI
SCI Self-Management for AIS D - Psychological Well-Being, Spinal Cord Injuries
Phase 1 / Phase 2WithdrawnVA Office of Research and Development2024-05-012026-03-13
Cannabinoids as a Treatment for Insomnia in Major Depression
25:1 CBD/THC, 5:1 CBD/THC, Placebo - Insomnia, Depressive Disorder, Major
Phase 2CompletedSt. Joseph's Healthcare Hamilton142023-08-282026-01-22
The CANabidiol Use for RElief of Short Term Insomnia
50 mg Cannabidiol (CBD), Placebo, 100 mg Cannabidiol (CBD) - Sleep Disturbance, Insomnia
Phase 2CompletedBod Australia2082022-05-012023-08-16
Oxytocin to Treat PTSD
Oxytocin, Placebo - PTSD
Phase 2CompletedVA Office of Research and Development1802021-01-012026-03-11
Peer Support Intervention to Mitigate Social Isolation and Stigma of Adolescent Motherhood in Zimbabwe
Young Women of Today - Mental Health Disorder, Social Isolation
Phase 2CompletedWest Chester University of Pennsylvania1832018-10-012022-02-15
Enhancing Delivery of Problem Solving Therapy Using SmartPhone Technology
Problem Solving Therapy plus Moving Forward, Problem Solving Therapy - Depression, Anxiety
Phase 1 / Phase 2CompletedVA Office of Research and Development332014-04-012016-11-28
Evaluation of an Intervention to Promote Physical Activity in Outpatients With Mental Disorders
Activity Intervention, Healthy Diet Intervention - Mental Disorders
Phase 2CompletedCharite University, Berlin, Germany862014-04-012016-03-10
Testing a Promising Treatment for Youth Substance Abuse in a Community Setting
Contingency Management-Family Engagement, Treatment as Usual - Substance Abuse, Delinquency
Phase 1 / Phase 2CompletedMedical University of South Carolina1012014-04-012018-07-06

Showing 20 of 41. Sign in to see all of them.

Narrower conditions

Depression (13)  ·  Anxiety Disorders (9)  ·  Stress Disorders, Post-Traumatic (6)  ·  Mental Disorders (5)  ·  Depressive Disorder, Major (3)  ·  Motor Activity (3)  ·  Phobia, Social (3)  ·  Sleep Initiation and Maintenance Disorders (3)  ·  Phobic Disorders (2)  ·  Sleep Wake Disorders (2)  ·  Substance-Related Disorders (2)  ·  Acquired Immunodeficiency Syndrome (1)  ·  Altruism (1)  ·  Anorexia Nervosa (1)

Broader conditions

Behavior (41)  ·  Personal Satisfaction (41)  ·  Mental Disorders (21)  ·  Behavioral Symptoms (15)  ·  Nervous System Diseases (6)  ·  Stress Disorders, Traumatic (6)  ·  Trauma and Stressor Related Disorders (6)  ·  Pathological Conditions, Signs and Symptoms (5)  ·  Signs and Symptoms (4)  ·  Social Behavior (4)  ·  Chemically-Induced Disorders (3)  ·  Depressive Disorder (3)  ·  Dyssomnias (3)  ·  Mood Disorders (3)  ·  Neurologic Manifestations (3)

Interventions

Cognitive Behavioral Therapy (4)  ·  Hypericum extract LI 160 (3)  ·  Psilocybin (2)  ·  (tris(diphenylphosphinomethyl)phenylborate)(p-tolylnitrido)iron(I) (1)  ·  Cannabidiol (1)  ·  Capsules (1)  ·  Cycloserine (1)  ·  Educational Status (1)  ·  Employment, Supported (1)  ·  Escitalopram (1)  ·  Health Promotion (1)  ·  Hyperbaric Oxygenation (1)  ·  Light (1)  ·  Modafinil (1)  ·  Motivational Interviewing (1)

Sponsors

VA Office of Research and Development (5)  ·  National Center for Complementary and Integrative Health (NCCIH) (4)  ·  Arizona State University (1)  ·  Bod Australia (1)  ·  Central Union for the Welfare of the Aged (1)  ·  Charite University, Berlin, Germany (1)  ·  Collinge and Associates, Inc. (1)  ·  Heidelberg University (1)  ·  Kansas State University (1)  ·  Kent State University (1)  ·  Massachusetts General Hospital (1)  ·  Mclean Hospital (1)  ·  Medical University of South Carolina (1)  ·  Monell Chemical Senses Center (1)  ·  Oregon Center for Applied Science, Inc. (1)

Countries

United States (29)  ·  Canada (2)  ·  Germany (2)  ·  United Kingdom (2)  ·  Australia (1)  ·  Finland (1)  ·  Peru (1)  ·  Sweden (1)

Top investigators

Kenneth Kobak, PhD (2)  ·  Adam Schickedanz, MD PhD (1)  ·  Amy Birney, MPH, MCHES (1)  ·  Anne Klibanski, MD (1)  ·  Baruch R Cahn, MD, PhD (1)  ·  Benicio N Frey, MD, MSc, PhD (1)  ·  Bert Hayslip, Ph.D. (1)  ·  Chiwoneso Tinago, PhD (1)  ·  Cynthia Price, PhD (1)  ·  Danielle Reed (1)  ·  Eli Puterman, PhD (1)  ·  Elizabeth B Khalil, BSc MSc PhD (Cant.) (1)  ·  Emily Schmied, PhD (1)  ·  Erinne Meenaghan, NP (1)

Results publications

PMID 18457236, PMID 20815872, PMID 21663696, PMID 23924065, PMID 24251855, PMID 24983382, PMID 27678169, PMID 30188171, PMID 31219558, PMID 32561468, PMID 33393377, PMID 33884617, PMID 36798485, PMID 37957412

NIH funding

I21RX004417 (1), K08MH001662 (1), R01HD115000 (1), R01HD116815 (1), R01MH077596 (1), R01MH083657 (1), R01NR012256 (1), R21MH066131 (1), R21NR011149 (1), R42MH087322 (1), R44DC022498 (1)